Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome

Antiplatelet drugs are prescribed without considering the diabetic status of the patient. The objective of the current investigation was to determine the impact of clinical factors, CYP4F2 enzyme and 20-hydroxyeicosatetraenoic acid (20-HETE) concentrations on high on-treatment platelet reactivity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatarunas, Vacis, Kupstyte-Kristapone, Nora, Zvikas, Vaidotas, Jakstas, Valdas, Zaliunas, Remigijus, Lesauskaite, Vaiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035295/
https://www.ncbi.nlm.nih.gov/pubmed/32081968
http://dx.doi.org/10.1038/s41598-020-59663-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035295/
https://www.ncbi.nlm.nih.gov/pubmed/32081968
http://dx.doi.org/10.1038/s41598-020-59663-3

Ejemplares similares